在抗甲状腺药物治疗期间，使用99锝研究甲状腺毒症患者的甲状腺功能。 - Suppr

Suppr

超能文献

Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs.

作者信息

Goolden A W, Williams E D, Thalassinos N C

出版信息

Clin Endocrinol (Oxf). 1973 Jan;2(1):65-73. doi: 10.1111/j.1365-2265.1973.tb03486.x.

DOI:10.1111/j.1365-2265.1973.tb03486.x

PMID:4770264

Abstract

摘要

相似文献

Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs.在抗甲状腺药物治疗期间，使用99锝研究甲状腺毒症患者的甲状腺功能。

Clin Endocrinol (Oxf). 1973 Jan;2(1):65-73. doi: 10.1111/j.1365-2265.1973.tb03486.x.

Sequential assessment during drug treatment of thyrotoxicosis.甲状腺毒症药物治疗期间的序贯评估。

Clin Endocrinol (Oxf). 1973 Jan;2(1):43-50. doi: 10.1111/j.1365-2265.1973.tb03483.x.

Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.甲状腺毒症抗甲状腺药物治疗长期疗效的预测

J Clin Endocrinol Metab. 1970 Apr;30(4):540-3. doi: 10.1210/jcem-30-4-540.

Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.普萘洛尔与卡比马唑作为甲状腺毒症的单一治疗方法。对循环甲状腺激素水平和组织甲状腺功能的考量。

Clin Endocrinol (Oxf). 1982 Jun;16(6):545-52. doi: 10.1111/j.1365-2265.1982.tb03171.x.

Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.停用抗甲状腺药物长期治疗甲状腺毒症后的甲状腺抑制性

Metabolism. 1969 Jan;18(1):58-62. doi: 10.1016/0026-0495(69)90133-4.

Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.抗甲状腺药物治疗甲状腺毒症后碘有机化缺陷。

Clin Endocrinol (Oxf). 1975 Jul;4(4):357-62. doi: 10.1111/j.1365-2265.1975.tb01544.x.

Self-limiting episodes of recurrent thyrotoxicosis.复发性甲状腺毒症的自限性发作

Lancet. 1971 Jan 2;1(7688):6-9. doi: 10.1016/s0140-6736(71)80002-8.

Functional activity of a thyroid nodule under the influence of stable iodide administration in a hyperthyroid patient.甲亢患者服用稳定碘后甲状腺结节的功能活动

Nuklearmedizin. 1979;18(6):293-6.

[Suppression of the thyroid by triiodothyronine].[三碘甲状腺原氨酸对甲状腺的抑制作用]

Bol Asoc Med P R. 1980 Sep;72(9):466-8.

The variation in serum triiodothyronine (T3) achieved during suppression testing in thyrotoxicosis.甲状腺毒症抑制试验期间血清三碘甲状腺原氨酸（T3）的变化。

Clin Endocrinol (Oxf). 1978 Dec;9(6):549-55. doi: 10.1111/j.1365-2265.1978.tb01513.x.

引用本文的文献

Are antithyroid drugs immunosuppressive?抗甲状腺药物具有免疫抑制作用吗？

Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):509-11. doi: 10.1136/bmj.288.6416.509.

Remission of hyperthyroidism.甲状腺功能亢进症的缓解。

Br Med J. 1973 Jul 14;3(5871):107-8. doi: 10.1136/bmj.3.5871.107-b.

In vivo tests of thyroid function.甲状腺功能的体内测试。

Br Med J. 1974 Sep 14;3(5932):678-81. doi: 10.1136/bmj.3.5932.678.

Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay.通过细胞化学生物测定法测量的卡比马唑治疗期间促甲状腺素免疫球蛋白生物活性。

J Endocrinol Invest. 1987 Oct;10(5):483-9. doi: 10.1007/BF03348175.

Tests of thyroid function in vivo.体内甲状腺功能测试。

J Clin Pathol. 1975 Mar;28(3):244-7. doi: 10.1136/jcp.28.3.244.

Assessment of thyroid function during and after treatment of thyrotoxicosis.甲状腺毒症治疗期间及治疗后的甲状腺功能评估。

J Clin Pathol. 1975 Mar;28(3):251-4. doi: 10.1136/jcp.28.3.251.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验